Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Denali Therapeutics (DNLI)
Technical Analysis Report for USA stock DNLI Denali Therapeutics. Dated: 04 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics then click here. or read Experts views on Denali Therapeutics or Forecast & share price targets of Denali Therapeutics
Denali Therapeutics Opened at 22.32 and Closed at: 22.28, which is -2.33% of previous session's close. It moved within a range of 22.15 and 22.48
The session was a Bearish session with an average volume of 799600, which is -116.1% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 5 days back on short term averages
A Dead cross was found 4 days back on mid term averages
Support for tomorrow is 22.05 and resistance for tomorrow is 22.38
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 22.13, 21.97 resistance for tomorrow's hourly charts is 22.46, 22.63
10 Day SMA for Denali Therapeutics (DNLI) is 23.73 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Denali Therapeutics (DNLI) is 24.29 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Denali Therapeutics (DNLI) is 24.38 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 22.43 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Denali Therapeutics is 20.86 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Denali Therapeutics is at 24.29 and 200 DMA is at 20.86, while 50 DMA and 100 DMA are at 24.38 and 22.43 respectively
Denali Therapeutics (DNLI) moving average of 20 SMA is at 24.29 and 20 EMA is at 23.9
| Date | Closing Price | 20 SMA | 20 EMA |
| 04 Fri Sep | 22.28 | 24.29 | 23.9 |
| 03 Thu Sep | 22.80 | 24.41 | 24.07 |
| 02 Wed Sep | 22.85 | 24.51 | 24.2 |
| 01 Tue Sep | 23.27 | 24.59 | 24.34 |
| 31 Mon Aug | 23.76 | 24.63 | 24.45 |
| 28 Fri Aug | 24.00 | 24.6 | 24.52 |
Denali Therapeutics (DNLI) moving average of 50 SMA is at 24.38 and 50 EMA is at 23.74
| Date | Closing Price | 50 SMA | 50 EMA |
| 04 Fri Sep | 22.28 | 24.38 | 23.74 |
| 03 Thu Sep | 22.80 | 24.45 | 23.8 |
| 02 Wed Sep | 22.85 | 24.49 | 23.84 |
| 01 Tue Sep | 23.27 | 24.53 | 23.88 |
| 31 Mon Aug | 23.76 | 24.56 | 23.9 |
| 28 Fri Aug | 24.00 | 24.56 | 23.91 |
Denali Therapeutics (DNLI) moving average of 100 SMA is at 22.43 and 100 EMA is at 22.8
| Date | Closing Price | 100 SMA | 100 EMA |
| 04 Fri Sep | 22.28 | 22.43 | 22.8 |
| 03 Thu Sep | 22.80 | 22.41 | 22.81 |
| 02 Wed Sep | 22.85 | 22.4 | 22.81 |
| 01 Tue Sep | 23.27 | 22.37 | 22.81 |
| 31 Mon Aug | 23.76 | 22.33 | 22.8 |
| 28 Fri Aug | 24.00 | 22.29 | 22.78 |
Denali Therapeutics (DNLI) moving average of 200 SMA is at 20.86 and 200 EMA is at 21.12
| Date | Closing Price | 200 SMA | 200 EMA |
| 04 Fri Sep | 22.28 | 20.86 | 21.12 |
| 03 Thu Sep | 22.80 | 20.83 | 21.11 |
| 02 Wed Sep | 22.85 | 20.81 | 21.09 |
| 01 Tue Sep | 23.27 | 20.78 | 21.07 |
| 31 Mon Aug | 23.76 | 20.75 | 21.05 |
| 28 Fri Aug | 24.00 | 20.72 | 21.02 |
Glaukos Corporation has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Glaukos Corporation, about 8.7% more returns!
Bristol Myers has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Bristol Myers, about 13.93% more returns!
Dentsply Sirona has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 8.48% more returns!
Phio Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 12.77% more returns!
Neogenomics Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Neogenomics Inc, about 15.39% more returns!
Lemaitre Vascular has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 10.24% more returns!
Dbv Technologies has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Dbv Technologies, about 5.27% more returns!
Denali Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Denali Therapeutics could be a better choice for now!
Celcuity Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Celcuity Inc, about 16.29% more returns!
Denali Therapeutics has performed better than Chemocentryx Inc in short term. Holding Denali Therapeutics could be a better choice for now!
Axogen Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Axogen Inc, about 11% more returns!
Atricure Inc has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Atricure Inc, about 34.61% more returns!
Assembly Biosciences has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Assembly Biosciences, about 47.75% more returns!
Amneal Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Amneal Pharmaceuticals, about 8.42% more returns!
Acadia Pharmaceuticals has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 6.22% more returns!
Arbutus Biopharma has performed better than Denali Therapeutics in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 22.86% more returns!
Denali Therapeutics Technical analysis of indicators
Price action analysis of Denali Therapeutics (DNLI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Denali Therapeutics in short term and the sell signal is strong.
Denali Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Denali Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Denali Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.6 and Denali Therapeutics DNLI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Denali Therapeutics DNLI stock. Volume based technical analysis of Denali Therapeutics DNLI stock is negative.
Denali Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock DNLI Denali Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And DNLI Experts View which covers a lot of information including buying and selling signals
DNLI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Denali Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Denali Therapeutics (DNLI) Technical (Analysis) Reports Denali Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


